Real impact across the genomics ecosystem.

Fava speaks at Genomics England Research Summit

Fava Health joined the Genomics England Research Summit in London, an annual event bringing together the UK and international genomics innovation ecosystem.

Returning research results to participants

We worked with the PROGRESS study team to build a participant-facing app for returning pharmacogenomic results from a real-world NHS research study.

Fava selected for Deep Tech Accelerator

Fava Health has joined the Unit M Deep Tech Accelerator, a three-month programme supporting technical founders and science-based start-ups from across Greater Manchester.

Fava selected for KQ Labs

Fava Health has joined KQ Labs Cohort 8, the accelerator programme delivered by the Francis Crick Institute for early-stage companies using data to transform healthcare.

Supporting large-scale PGx trial design

We worked with Ulster University and partners to support the implementation of pharmacogenomics within the iMPROVE project, a cross-border research trial focused on safer and more effective prescribing in primary care.

Viewpoint in EJHG

Our recent viewpoint in the European Journal of Human Genetics explores what it will take to move population genomics from scientific research into routine healthcare services.

Understanding perspectives on population genomics

We worked with Genomics England to understand public and healthcare professional perspectives on population-level genomic testing, helping inform the design of future engagement strategies and programme delivery.

Piloting end-to-end genomic testing

We worked with a local diagnostics company to design and deliver a real-world pharmacogenomic testing pathway for its employees, helping people understand how their genetic results could inform future prescribing.